Curr Control Trials Cardiovasc Med. 2000;1(2):76-78.

Debate: The slippery slope of surrogate outcomes.

Source

Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. rdagosti@wfubmc.edu

Abstract

Surrogate outcomes are frequently used in cardiovascular disease research. A concern is that changes in surrogate markers may not reflect changes in disease outcomes. Two recent clinical trials (Heart and Estrogen/Progestin Replacement Study [HERS], and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]) underscore this problem since their results contradicted what was expected based on the surrogate outcomes. The current regulatory policy to allow new therapies to be introduced onto the market based solely on surrogate outcomes may need to be reviewed.

PMID:: 11714414; [PubMed - as supplied by publisher]
PMCID:: PMC59603

Free PMC Article

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial--Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm. [Curr Opin Lipidol. 2003]
Review Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial--Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm.
Brown WV, Moussa M. Curr Opin Lipidol. 2003 Dec; 14(6):593-7.
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). [J Am Coll Cardiol. 2009]
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A, ALLHAT Collaborative Research Group. J Am Coll Cardiol. 2009 Nov 24; 54(22):2023-31.
Review Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension. [Ann Intern Med. 2001]
Review Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.
Furberg CD, Psaty BM, Pahor M, Alderman MH. Ann Intern Med. 2001 Dec 18; 135(12):1074-8.
Review Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome. [Can J Cardiol. 2004]
Review Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH. Can J Cardiol. 2004 Aug; 20 Suppl B:77B-82B.
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). [JAMA. 2002]
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, et al. JAMA. 2002 Jul 3; 288(1):58-66.

See reviews... See all...

Cited by 2 PubMed Central articles

Review What are biomarkers? [Curr Opin HIV AIDS. 2010]
Review What are biomarkers?
Strimbu K, Tavel JA. Curr Opin HIV AIDS. 2010 Nov; 5(6):463-6.
Withdrawal of cerivastatin from the world market. [Curr Control Trials Cardiovasc...]
Withdrawal of cerivastatin from the world market.
Furberg CD, Pitt B. Curr Control Trials Cardiovasc Med. 2001; 2(5):205-207.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Debate: The slippery slope of surrogate outcomes.
Debate: The slippery slope of surrogate outcomes.
Curr Control Trials Cardiovasc Med. 2000 ;1(2):76-78.

PubMed
Leptin in septic arthritis: decreased levels during infection and amelioration o...
Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration.
Arthritis Res. 2001 ;3(6):389-94. Epub 2001 Sep 19 .

PubMed
Betalains--a new class of dietary cationized antioxidants.
Betalains--a new class of dietary cationized antioxidants.
J Agric Food Chem. 2001 Nov ;49(11):5178-85.

PubMed
Myotonic dystrophy: opportunities for prenatal prediction.
Myotonic dystrophy: opportunities for prenatal prediction.
Neurology. 1975 Aug ;25(8):789-91.

PubMed
Linear mixture analysis: a mathematical approach to resolving mixed DNA samples.
Linear mixture analysis: a mathematical approach to resolving mixed DNA samples.
J Forensic Sci. 2001 Nov ;46(6):1372-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Debate: The slippery slope of surrogate outcomes.

Source

Abstract

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information